Roger Strode Featured in Q&A on the Rise of Private Equity Investments in Cardiology
February 15, 2023
Cardiovascular Business
Foley & Lardner LLP Partner Roger Strode is featured in the Cardiovascular Business Q&A “What the rise of private equity investments in cardiology means for cardiologists and their patients.”
Strode explains the trend of recapitalization transactions in the health care space, what makes cardiology so appealing to investors right now, and the long-term strategy of and perspectives on these investments.
People
Related News
March 13, 2026
In the News
Chris Babcock and Chris Converse on Wave of Companies Moving to Texas
Foley & Lardner LLP partners Chrisopher Babcock and Chris Converse commented on the widening trend of companies reincorporating to Texas in the Houston Business Journal article, “Texas law changes could spark wave of corporate redomestication proposals."
March 12, 2026
In the News
Louis Lehot Explores M&A's Growing Blitzhire Phenomenon
Foley & Lardner LLP partner Louis Lehot authors article on the emergence of blitzhires in the Mergers & Acquisitions article, “Blitzhires: The New Fast-Moving M&A Deal.”
March 10, 2026
In the News
Aaron Maguregui Shares Insights on Shadow AI Risks in Health Care
Foley & Lardner LLP partner Aaron Maguregui was quoted in the Part B News article, “Do you need AI policy? Experts suggest guardrails as 'shadow AI' spreads,” discussing the emerging risks of unsanctioned 'shadow AI' use by clinicians and the need to establish robust AI governance.